12 Health Care Stocks Moving In Tuesday's After-Market Session
Portfolio Pulse from Benzinga Insights
Several healthcare stocks experienced significant movement in Tuesday's after-market session. Gainers included Novo Integrated Sciences (NVOS), Nexalin Technology (NXL), T2 Biosystems (TTOO), MSP Recovery (LIFW), Alzamend Neuro (ALZN), and Tenon Medical (TNON). Losers included Impel Pharmaceuticals (IMPL), Tempest Therapeutics (TPST), Eloxx Pharmaceuticals (ELOX), Aeglea BioTherapeutics (AGLE), Kezar Life Sciences (KZR), and Cingulate (CING). Several companies recently released their Q2 earnings reports.
August 15, 2023 | 9:32 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Alzamend Neuro stock increased by 7.73% to $0.33.
The stock price increased significantly, indicating positive investor sentiment.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
MSP Recovery shares moved upwards by 14.19% to $0.14.
The stock price increased significantly, indicating positive investor sentiment.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Novo Integrated Sciences stock moved upwards by 23.5% to $0.14 during Tuesday's after-market session.
The stock price increased significantly, indicating positive investor sentiment.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Nexalin Technology stock increased by 17.82% to $0.72. The Q2 earnings report came out 3 days ago.
The stock price increased significantly, possibly due to a positive Q2 earnings report.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Tenon Medical shares moved upwards by 7.61% to $0.23.
The stock price increased significantly, indicating positive investor sentiment.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
T2 Biosystems shares moved upwards by 14.7% to $0.68.
The stock price increased significantly, indicating positive investor sentiment.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Aeglea BioTherapeutics shares decreased by 5.99% to $0.44. The Q2 earnings report came out 2 days ago.
The stock price decreased significantly, possibly due to a negative Q2 earnings report.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Cingulate stock decreased by 5.67% to $0.58. The Q2 earnings report came out yesterday.
The stock price decreased significantly, possibly due to a negative Q2 earnings report.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Eloxx Pharmaceuticals stock decreased by 6.54% to $5.13.
The stock price decreased significantly, indicating negative investor sentiment.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Impel Pharmaceuticals stock decreased by 33.3% to $0.72.
The stock price decreased significantly, indicating negative investor sentiment.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Kezar Life Sciences stock declined by 5.85% to $1.45. The Q2 earnings came out 3 days ago.
The stock price decreased significantly, possibly due to a negative Q2 earnings report.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Tempest Therapeutics shares fell 7.52% to $0.62. The Q2 earnings came out 3 days ago.
The stock price decreased significantly, possibly due to a negative Q2 earnings report.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100